Meditoxin 100 Units

Meditoxin 100UI

Meditoxin 100UI is designed for practitioners who want a standard clinic format without losing sight of the treatment objective. Built around botulinum toxin type A, it is positioned for temporary dynamic-line improvement, with its strongest practical fit linked to glabellar lines.

What Stands Out

For a professional buyer, the deciding points are concrete. Meditoxin 100UI should be assessed through its material profile, intended objective and exact presentation.

• Formulation focus: botulinum toxin type A
• Main professional objectives: temporary dynamic-line improvement
• Most relevant treatment areas: glabellar lines
• Presentation details: 100 units and lyophilised powder

Together, these details give Meditoxin 100UI a specific place in the catalogue and make comparison with neighbouring versions more useful.

1. Product and Unit Presentation

Meditoxin 100UI is positioned as standard 100-unit presentation for focused professional treatment planning. The relationship between its formulation, strength, presentation and professional objective defines this exact product more clearly than its category name alone.

2. Neuromuscular Action

Meditoxin 100UI works through botulinum toxin type A, which temporarily limits acetylcholine-mediated signalling between nerves and selected muscles. In professional aesthetic use, this controlled reduction in muscle activity can soften expression-related lines while allowing the treatment plan to be adapted to the area, muscle strength and desired degree of movement.

3. Aesthetic Treatment Objectives

• Softening dynamic expression lines
• Smoother-looking facial lines

4. Common Professional Applications

Meditoxin 100UI is commonly associated with:

• Forehead
• Glabellar lines
• Crow’s feet
• Bunny lines
• Lips and perioral area
• Nose
• Neck

For Meditoxin 100UI, area selection, quantity and technique remain part of the practitioner’s product-specific plan.

5. Composition and Vial Specifications

The formulation includes botulinum toxin type A, human serum albumin, and sodium chloride. The sealed label for Meditoxin 100UI remains the controlling reference for its exact ingredient statement.

• Product: Meditoxin 100UI
• Product type: Botulinum toxin type A product
• Meditoxin 100UI: Variant profile: Standard 100-unit presentation for focused professional treatment planning
• Reported strength or volume: 100UI
• Meditoxin 100UI: Reported formulation: botulinum toxin type A, human serum albumin, and sodium chloride
• Package details: single vial and lyophilized powder
• Meditoxin 100UI: Storage profile: refrigerated at 2°C to 8°C, do not freeze, and room-temperature storage is mentioned

6. Onset and Duration Profile

a duration of approximately 6-9 months is reported. Timing can vary with the treatment area, technique, quantity used and individual response, so the product should be evaluated by the progression and quality of the result rather than by one fixed timetable.

7. Reconstitution, Storage and Handling

The reported package presentation includes single vial and lyophilized powder. The available product information specifies refrigerated at 2°C to 8°C, do not freeze, and room-temperature storage is mentioned. The sealed outer box and current instructions remain the controlling handling reference.

8. Choosing the Correct Strength

For Meditoxin 100UI, the named variant must remain separate from other strengths in the same toxin family. A 50U, 100U, 200U or 300U presentation changes the total units available in the vial; it does not create an automatic one-to-one treatment plan, because dosing remains product- and practitioner-specific. The exact unit presentation should therefore be selected according to the intended professional use.

9. Frequently Asked Questions

What is Meditoxin 100UI?

For Meditoxin 100UI, the product is a botulinum toxin type A product positioned as standard 100-unit presentation for focused professional treatment planning. Its page is built around the exact formulation and presentation rather than a generic description of the category.

What is the main purpose of Meditoxin 100UI?

For this presentation, its product profile centres on softening dynamic expression lines and smoother-looking facial lines. The final treatment objective and technique are selected by a qualified professional.

What does Meditoxin 100UI contain?

For Meditoxin 100UI, for this formulation, available product information describes botulinum toxin type A, human serum albumin, and sodium chloride.

Which areas are associated with Meditoxin 100UI?

The product information associates the product with forehead, glabellar lines, crow’s feet, bunny lines, lips and perioral area, nose, and neck. Suitability and placement depend on the exact product instructions and individual assessment.

How is Meditoxin 100UI supplied?

For Meditoxin 100UI, this formulation is described with single vial and lyophilized powder. Current outer-box information remains the controlling reference for the received market presentation.

What makes this exact version different?

For Meditoxin 100UI, this formulation must remain separate from other strengths in the same toxin family. A 50U, 100U, 200U or 300U presentation changes the total units available in the vial; it does not create an automatic one-to-one treatment plan, because dosing remains product- and practitioner-specific. The exact unit presentation should therefore be selected according to the intended professional use.

10. Professional Use

Manufacturer-Confirmed Details

Medytox describes Meditoxin/Neuronox as botulinum toxin type A derived from the Hall strain and presented as a lyophilised white powder for injection in a colourless transparent vial. The manufacturer lists a one-vial package and storage either frozen at −15 to −5°C or refrigerated at 2–8°C, subject to the exact regional label.